Free radical scavenging and cellular antioxidant properties of astaxanthin

International Journal of Molecular Sciences

Volumn 17, Issue 1, 2016, Pages

  Dose, Janina ^a   Matsugo, Seiichi ^b   Yokokawa, Haruka ^b   Koshida, Yutaro ^b   Okazaki, Shigetoshi ^c   Seidel, Ulrike ^a   Eggersdorfer, Manfred ^d   Rimbach, Gerald ^a   Esatbeyoglu, Tuba ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b KANAZAWA UNIVERSITY   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d DSM NUTRITIONAL PRODUCTS LTD   (Switzerland)

Author keywords

Antioxidant; Astaxanthin; Electron spin resonance spectroscopy; Free radical scavenging

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ARYLDIALKYLPHOSPHATASE 1; ASTAXANTHIN; FREE RADICAL; GALVINOXYL; GLUTATHIONE; NEUTRAL RED; OXYGEN; SINGLET OXYGEN; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; XANTHINE OXIDASE; SCAVENGER; XANTHOPHYLL;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL CULTURE; CELL VIABILITY ASSAY; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DPPH RADICAL SCAVENGING ASSAY; ELECTRON SPIN RESONANCE; ENZYME ACTIVITY; ENZYME INHIBITION; FREE RADICAL SCAVENGING ASSAY; HUMAN; HUMAN CELL; LIPID PEROXIDATION; LIVER CELL; NEAR INFRARED SPECTROSCOPY; PHOTOCHEMICAL QUENCHING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SPIN TRAPPING; TRANSACTIVATION; CELL LINE; DRUG EFFECTS; HEP-G2 CELL LINE; METABOLISM;

CELL LINE; FREE RADICAL SCAVENGERS; HEP G2 CELLS; HEPATOCYTES; HUMANS; LIPID PEROXIDATION; XANTHOPHYLLS;

EID: 84954312628     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17010103     Document Type: Article

References (50)

1. Ambati, R.R.; Phang, S.M.; Ravi, S.; Aswathanarayana, R.G. Astaxanthin: Sources, extraction, stability, biological activities and its commercial applications-A review. Mar. Drugs 2014, 12, 128-152. [CrossRef] [PubMed]
2. Jiao, G.; Hui, J.P.M.; Burton, I.W.; Thibault, M.-H.; Pelletier, C.; Boudreau, J.; Tchoukanova, N.; Subramanian, B.; Djaoued, Y.; Ewart, S.; et al. Characterization of shrimp oil from Pandalus borealis by high performance liquid chromatography and high resolution mass spectrometry. Mar. Drugs 2015, 13, 3849-3876. [CrossRef] [PubMed]
3. Higuera-Ciapara, I.; Félix-Valenzuela, L.; Goycoolea, F.M. Astaxanthin: A review of its chemistry and applications. Crit. Rev. Food Sci. Nutr. 2006, 46, 185-196. [CrossRef] [PubMed]
4. Otton, R.; Marin, D.P.; Bolin, A.P.; de Cássia Santos Macedo, R.; Campoio, T.R.; Fineto, C.; Guerra, B.A.; Leite, J.R.; Barros, M.P.; Mattei, R. Combined fish oil and astaxanthin supplementation modulates rat lymphocyte function. Eur. J. Nutr. 2012, 51, 707-718. [CrossRef] [PubMed]
5. Megdal, P.A.; Craft, N.A.; Handelman, G.J. A simplified method to distinguish farmed (Salmo salar) from wild salmon: Fatty acid ratios versus astaxanthin chiral isomers. Lipids 2009, 44, 569-576. [CrossRef] [PubMed]
6. Widmer, E.; Zell, R.; Broger, E.A.; Crameri, Y.;Wagner, H.P.; Dinkel, J.; Schlageter, M.; Lukáč, T. Technische Verfahren zur Synthese von Carotinoiden und verwandten Verbindungen aus 6-Oxo-isophoron. II. Ein neues Konzept für die Synthese von (3RS, 3RS)-Astaxanthin. Helv. Chim. Acta 1981, 64, 2436-2446. (In German). [CrossRef]
7. Guerin, M.; Huntley, M.E.; Olaizola, M. Haematococcus astaxanthin: Applications for human health and nutrition. Trends Biotechnol. 2003, 21, 210-216. [CrossRef]
8. Fassett, R.G.; Coombes, J.S. Astaxanthin: A potential therapeutic agent in cardiovascular disease. Mar. Drugs 2011, 9, 447-465. [CrossRef] [PubMed]
9. Hashimoto, H.; Arai, K.; Hayashi, S.; Okamoto, H.; Takahashi, J.; Chikuda, M.; Obara, Y. Effects of astaxanthin on antioxidation in human aqueous humor. J. Clin. Biochem. Nutr. 2013, 53, 1-7. [CrossRef] [PubMed]
10. Fassett, R.G.; Healy, H.; Driver, R.; Robertson, I.K.; Geraghty, D.P.; Sharman, J.E.; Coombes, J.S. Astaxanthin vs placebo on arterial stiffness, oxidative stress and inflammation in renal transplant patients (Xanthin): A randomised controlled trial. BMC Nephrol. 2008, 9, 17. [CrossRef] [PubMed]
11. Rodrigues, E.; Mariutti, L.R.B.; Mercadante, A.Z. Scavenging capacity of marine carotenoids against reactive oxygen and nitrogen species in a membrane-mimicking system. Mar. Drugs 2012, 10, 1784-1798. [CrossRef] [PubMed]
12. Rao, A.R.; Sarada, R.; Shylaja, M.D.; Ravishankar, G.A. Evaluation of hepatoprotective and antioxidant activity of astaxanthin and astaxanthin esters from microalga-Haematococcus pluvialis. J. Food Sci. Technol. 2015, 52, 6703-6710. [CrossRef] [PubMed]
13. Saw, C.L.L.; Yang, A.Y.; Guo, Y.; Kong, A.N.T. Astaxanthin and omega-3 fatty acids individually and in combination protect against oxidative stress via the Nrf2-ARE pathway. Food Chem. Toxicol. 2013, 62, 869-875. [CrossRef] [PubMed]
14. Kavitha, K.; Kowshik, J.; Kishore, T.K.K.; Baba, A.B.; Nagini, S. Astaxanthin inhibits NF-κB and Wnt/β-catenin signaling pathways via inactivation of Erk/MAPK and PI3K/Akt to induce intrinsic apoptosis in a hamster model of oral cancer. Biochim. Biophys. Acta 2013, 1830, 4433-4444. [CrossRef] [PubMed]
15. Lee, S.-J.; Bai, S.-K.; Lee, K.-S.; Namkoong, S.; Na, H.-J.; Ha, K.-S.; Han, J.-A.; Yim, S.-V.; Chang, K.; Kwon, Y.-G.; et al. Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing IκB kinase-dependent NF-κB activation. Mol. Cells 2003, 16, 97-105. [PubMed]
16. Polotow, T.G.; Vardaris, C.V.; Mihaliuc, A.R.; Gonçalves, M.S.; Pereira, B.; Ganini, D.; Barros, M.P. Astaxanthin supplementation delays physical exhaustion and prevents redox imbalances in plasma and soleus muscles ofWistar rats. Nutrients 2014, 6, 5819-5838. [CrossRef] [PubMed]
17. Régnier, P.; Bastias, J.; Rodriguez-Ruiz, V.; Caballero-Casero, N.; Caballo, C.; Sicilia, D.; Fuentes, A.; Maire, M.; Crepin, M.; Letourneur, D.; et al. Astaxanthin from Haematococcus pluvialis prevents oxidative stress on human endothelial cells without toxicity. Mar. Drugs 2015, 13, 2857-2874. [CrossRef] [PubMed]
18. Sueishi, Y.; Ishikawa, M.; Yoshioka, D.; Endoh, N.; Oowada, S.; Shimmei, M.; Fujii, H.; Kotake, Y. Oxygen radical absorbance capacity (ORAC) of cyclodextrin-solubilized flavonoids, resveratrol and astaxanthin as measured with the ORAC-EPR method. J. Clin. Biochem. Nutr. 2012, 50, 127-132. [CrossRef] [PubMed]
19. Litwinienko, G.; Ingold, K.U. Abnormal solvent effects on hydrogen atom abstractions. 1. The reactions of phenols with 2,2-diphenyl-1-picrylhydrazyl (dpph*) in alcohols. J. Org. Chem. 2003, 68, 3433-3438. [CrossRef] [PubMed]
20. Litwinienko, G.; Ingold, K.U. Abnormal solvent effects on hydrogen atom abstraction. 2. Resolution of the curcumin antioxidant controversy. The role of sequential proton loss electron transfer. J. Org. Chem. 2004, 69, 5888-5896. [CrossRef] [PubMed]
21. Litwinienko, G.; Ingold, K.U. Solvent effects on the rates and mechanisms of reaction of phenols with free radicals. Acc. Chem. Res. 2007, 40, 222-230. [CrossRef] [PubMed]
22. Aruoma, O.I. Methodological considerations for characterizing potential antioxidant actions of bioactive components in plant foods. Mutat. Res. 2003, 523-524, 9-20. [CrossRef]
23. Rimbach, G.; Höhler, D.; Fischer, A.; Roy, S.; Virgili, F.; Pallauf, J.; Packer, L. Methods to assess free radicals and oxidative stress in biological systems. Arch. Tierernahr. 1999, 52, 203-222. [CrossRef] [PubMed]
24. Dong, S.; Huang, Y.; Zhang, R.; Wang, S.; Liu, Y. Four different methods comparison for extraction of astaxanthin from green alga Haematococcus pluvialis. Sci. World J. 2014, 2014, 694305. [CrossRef] [PubMed]
25. Yuan, C.; Du, L.; Jin, Z.; Xu, X. Storage stability and antioxidant activity of complex of astaxanthin with hydroxypropyl-β-cyclodextrin. Carbohydr. Polym. 2013, 91, 385-389. [CrossRef] [PubMed]
26. Zhang, J.; Sun, Z.; Sun, P.; Chen, T.; Chen, F. Microalgal carotenoids: Beneficial effects and potential in human health. Food Funct. 2014, 5, 413-425. [CrossRef] [PubMed]
27. Papa, T.B.R.; Pinho, V.D.; do Nascimento, E.S.P.; Santos,W.G.; Burtoloso, A.C.B.; Skibsted, L.H.; Cardoso, D.R. Astaxanthin diferulate as a bifunctional antioxidant. Free Radic. Res. 2015, 49, 102-111. [CrossRef] [PubMed]
28. Ytrestøyl, T.; Bjerkeng, B. Intraperitoneal and dietary administration of astaxanthin in rainbow trout (Oncorhynchus mykiss)-Plasma uptake and tissue distribution of geometrical E/Z isomers. Comp. Biochem. Physiol. B 2007, 147, 250-259. [CrossRef] [PubMed]
29. Mladenka, P.; Zatloukalová, L.; Filipsky, T.; Hrdina, R. Cardiovascular effects of flavonoids are not caused only by direct antioxidant activity. Free Radic. Biol. Med. 2010, 49, 963-975. [CrossRef] [PubMed]
30. Moini, H.; Guo, Q.; Packer, L. Xanthine oxidase and xanthine dehydrogenase inhibition by the procyanidin-rich French maritime pine bark extract, pycnogenol: A protein binding effect. Adv. Exp. Med. Biol. 2002, 505, 141-149. [PubMed]
31. Boesch-Saadatmandi, C.; Rimbach, G.; Jungblut, A.; Frank, J. Comparison of tetrahydrofuran, fetal calf serum, and Tween 40 for the delivery of astaxanthin and canthaxanthin to HepG2 cells. Cytotechnology 2011, 63, 89-97. [CrossRef] [PubMed]
32. Briviba, K.; Bornemann, R.; Lemmer, U. Visualization of astaxanthin localization in HT29 human colon adenocarcinoma cells by combined confocal resonance Raman and fluorescence microspectroscopy. Mol. Nutr. Food Res. 2006, 50, 991-995. [CrossRef] [PubMed]
33. Schrader, C.; Rimbach, G. Determinants of paraoxonase 1 status: Genes, drugs and nutrition. Curr. Med. Chem. 2011, 18, 5624-5643. [CrossRef] [PubMed]
34. Baralic, I.; Djordjevic, B.; Dikic, N.; Kotur-Stevuljevic, J.; Spasic, S.; Jelic-Ivanovic, Z.; Radivojevic, N.; Andjelkovic, M.; Pejic, S. Effect of astaxanthin supplementation on paraoxonase 1 activities and oxidative stress status in young soccer players. Phytother. Res. 2013, 27, 1536-1542. [CrossRef] [PubMed]
35. Rao, A.R.; Sindhuja, H.N.; Dharmesh, S.M.; Sankar, K.U.; Sarada, R.; Ravishankar, G.A. Effective inhibition of skin cancer, tyrosinase, and antioxidative properties by astaxanthin and astaxanthin esters from the green alga Haematococcus pluvialis. J. Agric. Food Chem. 2013, 61, 3842-3851. [CrossRef] [PubMed]
36. Capelli, B.; Bagchi, D.; Cysewski, G.R. Synthetic astaxanthin is significantly inferior to algal-based astaxanthin as an antioxidant and may not be suitable as a human nutraceutical supplement. Nutrafoods 2014, 12, 145-152. [CrossRef]
37. Morales, A.; García-Ruiz, C.; Miranda, M.; Marí, M.; Colell, A.; Ardite, E.; Fernández-Checa, J.C. Tumor necrosis factor increases hepatocellular glutathione by transcriptional regulation of the heavy subunit chain of -glutamylcysteine synthetase. J. Biol. Chem. 1997, 272, 30371-30379. [CrossRef] [PubMed]
38. Morales, A.; Miranda, M.; Sanchez-Reyes, A.; Colell, A.; Biete, A.; Fernández-Checa, J.C. Transcriptional regulation of the heavy subunit chain of -glutamylcysteine synthetase by ionizing radiation. FEBS Lett. 1998, 427, 15-20. [CrossRef]
39. Moffat, G.J.; McLaren, A.W.; Wolf, C.R. Sp1-mediated transcriptional activation of the human Pi class glutathione S-transferase promoter. J. Biol. Chem. 1996, 271, 1054-1060. [CrossRef] [PubMed]
40. Ye, Q.; Zhang, X.; Huang, B.; Zhu, Y.; Chen, X. Astaxanthin suppresses MPP+-induced oxidative damage in PC12 cells through a Sp1/NR1 signaling pathway. Mar. Drugs 2013, 11, 1019-1034. [CrossRef] [PubMed]
41. Myhrstad, M.C.; Husberg, C.; Murphy, P.; Nordström, O.; Blomhoff, R.; Moskaug, J.O.; Kolstø, A.B. TCF11/Nrf1 overexpression increases the intracellular glutathione level and can transactivate the -glutamylcysteine synthetase (GCS) heavy subunit promoter. Biochim. Biophys. Acta 2001, 1517, 212-219. [CrossRef]
42. Yang, H.; Magilnick, N.; Lee, C.; Kalmaz, D.; Ou, X.; Chan, J.Y.; Lu, S.C. Nrf1 and Nrf2 regulate rat glutamate-cysteine ligase catalytic subunit transcription indirectly via NF-κB and AP-1. Mol. Cell. Biol. 2005, 25, 5933-5946. [CrossRef] [PubMed]
43. Kurozumi, R.; Kojima, S. Increase of intracellular glutathione by low-level NO mediated by transcription factor NF-κB in RAW264.7 cells. Biochim. Biophys. Acta 2005, 1744, 58-67. [CrossRef] [PubMed]
44. Lababpour, A.; Lee, C.-G. Simultaneous measurement of chlorophyll and astaxanthin in Haematococcus pluvialis cells by first-order derivative ultraviolet-visible spectrophotometry. J. Biosci. Bioeng. 2006, 101, 104-110. [CrossRef] [PubMed]
45. Bräunlich, M.; Slimestad, R.; Wangensteen, H.; Brede, C.; Malterud, K.E.; Barsett, H. Extracts, anthocyanins and procyanidins from Aronia melanocarpa as radical scavengers and enzyme inhibitors. Nutrients 2013, 5, 663-678. [CrossRef] [PubMed]
46. Shimizu, T.; Nakanishi, Y.; Nakahara, M.; Wada, N.; Moro-oka, Y. Radical on structure effect antioxidant activity of catecholamines toward singlet oxygen and other reactive oxygen species in vitro. J. Clin. Biochem. Nutr. 2010, 47, 181-190. [CrossRef] [PubMed]
47. Boesch-Saadatmandi, C.; Egert, S.; Schrader, C.; Coumoul, X.; Barouki, R.; Muller, M.J.; Wolffram, S.; Rimbach, G. Effect of quercetin on paraoxonase 1 activity-studies in cultured cells, mice and humans. J. Physiol. Pharmacol. 2010, 61, 99-105. [PubMed]
48. Esatbeyoglu, T.; Wagner, A.E.; Motafakkerazad, R.; Nakajima, Y.; Matsugo, S.; Rimbach, G. Free radical scavenging and antioxidant activity of betanin: Electron spinresonance spectroscopy studies and studies in cultured cells. Food Chem. Toxicol. 2014, 73, 119-126. [CrossRef] [PubMed]
49. Vandeputte, C.; Guizon, I.; Genestie-Denis, I.; Vannier, B.; Lorenzon, G. A microtiter plate assay for total glutathione and glutathione disulfide contents in cultured/isolated cells: Performance study of a new miniaturized protocol. Cell Biol. Toxicol. 1994, 10, 415-421. [CrossRef] [PubMed]
50. Wagner, A.E.; Ernst, I.; Iori, R.; Desel, C.; Rimbach, G. Sulforaphane but not ascorbigen, indole-3-carbinole and ascorbic acid activates the transcription factor Nrf2 and induces phase-2 and antioxidant enzymes in human keratinocytes in culture. Exp. Dermatol. 2010, 19, 137-144. [CrossRef] [PubMed]